PAVmed (PAVM) Cash from Investing Activities (2016 - 2025)
PAVmed (PAVM) recorded quarterly Cash from Investing Activities of -$14000.0 in Q4 2025, down 366.67% quarter-over-quarter from -$3000.0 in Q3 2025, and down 250.0% on a YoY basis from $9333.3 in Q4 2024.
PAVmed (PAVM) Cash from Investing Activities (2016 - 2025) Analysis & Trends
PAVmed's Cash from Investing Activities history runs 10 years deep, the most recent figure standing at -$14000.0 for Q4 2025.
- In Q4 2025, Cash from Investing Activities fell 250.0% year-over-year to -$14000.0; the TTM figure through Dec 2025 stood at -$31000.0 (up 86.64% YoY), while the FY2025 annual figure was -$31000.0, up 99.81% from the prior year.
- Cash from Investing Activities was -$14000.0 for Q4 2025 at PAVmed, down from -$3000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $974000.0 in Q1 2023 to a low of -$3.4 million in Q4 2021.
- Historically, Cash from Investing Activities has averaged -$409368.4 across 5 years, with a median of -$36000.0 in 2021.
- The sharpest annual moves came in 2021 and 2023: Cash from Investing Activities tumbled 42112.5% in 2021, then jumped 269.69% in 2023.
- A 5-year view of Cash from Investing Activities shows it stood at -$3.4 million in 2021, then jumped by 91.18% to -$298000.0 in 2022, then surged by 38.59% to -$183000.0 in 2023, then surged by 97.81% to -$4000.0 in 2024, then plunged by 250.0% to -$14000.0 in 2025.
- The last three Cash from Investing Activities figures came in at -$14000.0 (Q4 2025), -$3000.0 (Q3 2025), and -$8000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -92.80 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -2.50 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -298.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -217.20 Mn |
| 10 | PAVmed | 3.32 Mn | -9.85 Mn | -703,000.00 | -14,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14,000.00 |
| Dec 31, 2025 | -14,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -8,000.00 |
| Jun 30, 2025 | -8,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Dec 31, 2024 | -4,000.00 |
| Dec 31, 2024 | -4,000.00 |
| Jun 30, 2024 | -3,000.00 |
| Jun 30, 2024 | -3,000.00 |
| Mar 31, 2024 | -42,000.00 |
| Mar 31, 2024 | -42,000.00 |
| Dec 31, 2023 | -183,000.00 |
| Dec 31, 2023 | -183,000.00 |
| Sep 30, 2023 | -18,000.00 |
| Sep 30, 2023 | -18,000.00 |
| Jun 30, 2023 | -15,000.00 |
| Jun 30, 2023 | -15,000.00 |